MedMira Inc (MIR.V)
0.08
0.00 (0.00%)
CAD |
TSXV |
Jun 21, 16:00
MedMira Enterprise Value: 62.28M for June 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 21, 2024 | 62.28M |
| June 20, 2024 | 62.28M |
| June 19, 2024 | 62.28M |
| June 18, 2024 | 65.79M |
| June 17, 2024 | 65.79M |
| June 14, 2024 | 69.30M |
| June 13, 2024 | 65.79M |
| June 12, 2024 | 62.28M |
| June 11, 2024 | 65.79M |
| June 10, 2024 | 65.79M |
| June 07, 2024 | 65.79M |
| June 06, 2024 | 65.79M |
| June 05, 2024 | 62.28M |
| June 04, 2024 | 62.28M |
| June 03, 2024 | 69.30M |
| May 31, 2024 | 69.30M |
| May 30, 2024 | 65.79M |
| May 29, 2024 | 65.79M |
| May 28, 2024 | 65.79M |
| May 27, 2024 | 69.30M |
| May 24, 2024 | 69.30M |
| May 23, 2024 | 65.79M |
| May 22, 2024 | 69.30M |
| May 21, 2024 | 72.81M |
| May 17, 2024 | 72.81M |
| Date | Value |
|---|---|
| May 16, 2024 | 69.30M |
| May 15, 2024 | 72.81M |
| May 14, 2024 | 69.30M |
| May 13, 2024 | 72.81M |
| May 10, 2024 | 65.79M |
| May 09, 2024 | 69.30M |
| May 08, 2024 | 72.81M |
| May 07, 2024 | 69.30M |
| May 06, 2024 | 69.30M |
| May 03, 2024 | 69.30M |
| May 02, 2024 | 72.81M |
| May 01, 2024 | 62.28M |
| April 30, 2024 | 65.79M |
| April 29, 2024 | 62.28M |
| April 26, 2024 | 58.77M |
| April 25, 2024 | 58.77M |
| April 24, 2024 | 58.77M |
| April 23, 2024 | 58.77M |
| April 22, 2024 | 58.77M |
| April 19, 2024 | 58.77M |
| April 18, 2024 | 62.28M |
| April 17, 2024 | 62.28M |
| April 16, 2024 | 65.79M |
| April 15, 2024 | 69.30M |
| April 12, 2024 | 69.30M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
11.54M
Minimum
Jun 25 2019
469.91M
Maximum
May 26 2020
102.32M
Average
82.83M
Median
Aug 04 2022
Enterprise Value Benchmarks
| Biocure Technology Inc | 1.450M |
| Core One Labs Inc | 6.689M |
| Nova Mentis Life Science Corp | 3.005M |
| Nanosphere Health Sciences Inc | 0.5028M |
| Lobe Sciences Ltd | 2.834M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.5908M |
| Revenue (Quarterly) | 0.1487M |
| Total Expenses (Quarterly) | 0.5168M |
| EPS Diluted (Quarterly) | -0.001 |
| Gross Profit Margin (Quarterly) | 45.82% |
| Profit Margin (Quarterly) | -397.3% |
| Earnings Yield | -5.38% |
| Normalized Earnings Yield | -5.375 |